Recruiting PHASE3 INTERVENTIONAL 2-arm
NCT06848374
Dose Efficacy in Adhesive Capsulitis
Dose Comparison for the Treatment of Adhesive Capsulitis with Hydrodilatation and Corticosteroid Using an Anterior Approach Under Ultrasound-Guidance
Sponsor: University Health Network, Toronto
Conditions
Adhesive Capsulitis of the Shoulder
Interventions
40 mg Methylprednisolone 80 mg Methylprednisolone
Updated 1 time since 2025 Last updated: Feb 23, 2025 Started: Dec 20, 2024 Primary completion: Jun 30, 2026 Completion: Dec 31, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A PHASE3 clinical study on Adhesive Capsulitis of the Shoulder, this trial is actively recruiting participants. The trial is conducted by University Health Network, Toronto and has accumulated 1 data snapshot since 2024. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
1 version recorded Recruiting — PHASE3
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- University Health Network, Toronto
Data source: University Health Network, Toronto
For direct contact, visit the study record on ClinicalTrials.gov .